awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33414243-1A03E937-9216-4B6D-ACA4-070ABD10D659
Q33414243-1A03E937-9216-4B6D-ACA4-070ABD10D659
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414243-1A03E937-9216-4B6D-ACA4-070ABD10D659
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.
P2860
Q33414243-1A03E937-9216-4B6D-ACA4-070ABD10D659
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414243-1A03E937-9216-4B6D-ACA4-070ABD10D659
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c5d8483bd43a0390bb5b810c492f7716e8573391
P2860
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.